‘NVIDIA to Acquire DeepMap, Enhancing Mapping Solutions for the AV Industry’ -From NVIDIA Blog Late Thursday

https://blogs.nvidia.com/blog/2021/06/10/nvidia-deepmap-mapping-drive-platform/

byBenzinga Newsdesk

June 11, 2021

1 minute read

https://blogs.nvidia.com/blog/2021/06/10/nvidia-deepmap-mapping-drive-platform/

GSK Spurns $68.4B Bid From Unilever For Its Consumer Healthcare Business, Opts to Spin-off The Unit

By Shanthi Rexaline

Today, 11:03 PM

GlaxoSmithKline rejects three purchase offers from Unilever for its Consumer Healthcare business. The U.K. pharma giant says the business is well-positioned to sustainably grow ahead of its categories in the years to come.

GSK

On Jan 17, Aveo Oncology’s Lg Chem Received Written Notice From CFIUS That There Were No Unresolved National Security Concerns Regarding Transaction; All Required Regulatory Approvals To Complete Merger Have Now Been Received

By Benzinga Newsdesk

Today, 11:03 PM

As previously disclosed, on October 18, 2022, AVEO Pharmaceuticals, Inc., a Delaware corporation (“AVEO”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) with LG Chem,

AVEO

Aditxt Signs Transaction Agreement To Acquire Subsidiary Of AiPharma

By Bill Haddad

Today, 11:03 PM

Aditxt Signs a Transaction Agreement to Acquire AiPharma, Rights Holder of Antiviral Tablet Avigan/Reeqonus/Qifenda Used in the Treatment of Over 1.5 Million COVID-19 Patients Outside the U.S. and Canada

ADTX

AstraZeneca to Transfer Global Rights for Eklira and Duaklir to Covis Pharma for $270M

By Charles Gross

Today, 11:03 PM

AstraZeneca has agreed to transfer its global rights to Eklira (aclidinium bromide), known as Tudorza in the US, and Duaklir (aclidinium bromide/formoterol) to Covis Pharma Group (Covis Pharma). Both medicines are delivered via the Genuair device and used for the treatment of patients with chronic obstructive pulmonary disease (COPD).

AZN

‘NVIDIA to Acquire DeepMap, Enhancing Mapping Solutions for the AV Industry’ -From NVIDIA Blog Late Thursday

Related Posts

GSK Spurns $68.4B Bid From Unilever For Its Consumer Healthcare Business, Opts to Spin-off The Unit

On Jan 17, Aveo Oncology’s Lg Chem Received Written Notice From CFIUS That There Were No Unresolved National Security Concerns Regarding Transaction; All Required Regulatory Approvals To Complete Merger Have Now Been Received

Aditxt Signs Transaction Agreement To Acquire Subsidiary Of AiPharma

AstraZeneca to Transfer Global Rights for Eklira and Duaklir to Covis Pharma for $270M